ClinicalTrials.gg
CompletedNCT05155826VIRTUALMAGUpdated Jun 30, 2026

Effect of Virtual Reality for Pain Management During Intracervical Balloon Placement for Artificial Childbirth Induction

An interventional study of Virtual Reality Headset in Delivery Problem and Labor Pain, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The labor induction concerns 22% of births in France. In the event of labor induction, in almost two thirds of cases, a cervical ripening method is used and the use of mechanical methods is observed for 8% of cervical ripening. Intra-cervical balloon placement is generally well tolerated but is frequently associated with pain and acute anxiety. There are few options for pain relief. Virtual reality, a relatively new intervention, has been studied as a distraction technique for pain relief, but never in the context of the induction of childbirth.

Read the detailed description

It's prospective single-center, randomized, single-blind, prospective study (1:1, 2 group randomization) comparing a group of patients who benefited from the use of the virtual reality headset to a group of patients who received standard care during balloon insertion. Two groups of patients will be formed: a "standard care" group and a "standard care + virtual reality" group.

The study will take place at the Saint-Etienne University Hospital Center in the gynecology-obstetrics department.

The principal objective is to evaluate the effectiveness of the use of a virtual reality helmet on the reduction of pain during the insertion of an intra-cervical balloon for childbirth induction versus the use of standard care.

02

Conditions studied

  • Delivery Problem
  • Labor Pain

Keywords

  • labor induction
  • intra-cervical balloon
  • pain
  • virtual reality
  • Cook®
03

In context

Dystocia

55 studies on the registry are indexed under Dystocia; 12 are open to participants now.

This study's enrollment of 60 is below the median of 200 across 42 interventional studies indexed under Dystocia.

Browse Dystocia studies →

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 597 studies on the registry; 127 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any pregnant woman presenting to the Gynecology-Obstetrics Department of the Saint-Etienne University Hospital for an induction by Cook's balloon.
  • Patients affiliated or entitled to a social security system
  • Patients having given their agreement to participate and after signing the consent form

Exclusion criteria

Exclusion Criteria:

  • Woman refusing to participate in the study (lack of consent)
  • Non French-speaking woman (impossibility of carrying out a good quality interview of the pregnant woman)
  • Women suffering from blindness, deafness or epilepsy against the use of the virtual reality helmet.
  • Participation in another interventional study.
  • Patient under guardianship or curatorship
  • Patient subject to a legal protection measure or unable to express their consent
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    standard care (control group)

    Patient benefit the standard care during the placement of Cook's balloon (standard care).

  • Experimental
    standard care and virtual reality (experimental group)

    Patient benefit the standard care during placement of Cook's balloon (standard care) with the use of a virtual reality.

    Device: Virtual Reality Headset

Interventions

  • DeviceVirtual Reality Headset

    The patient will benefit from the placement of Cook's balloon (standard care) with the placement of the virtual reality headset on the examination table with the launch of the software before the beginning of the procedure. The virtual reality helmet will be removed at the end of the procedure.

    Also known as: Deepsen® VRx and Shenzhen Huajin® electronics Co

06

What researchers measure

Primary outcomes

  1. maximum pain felt during balloon placement

    Measurement of the maximum pain experienced during the placement of the intra-cervical balloon using a numerical scale from 0 to 10: 0 = no pain, 10 = maximum pain.

    Time frame: Day: 0

Secondary outcomes

  1. average pain felt during balloon placement

    Average pain felt during balloon placement measured by a numerical scale from 0 to 10. (0 no pain - 10 maximum pain).

    Time frame: Day: 0

  2. Nociception Level Index (NOL™) during balloon placement

    Measured Nociception Level Index (NOL ™) calculated by the PMD200 Pain Monitor™. Nociception Level Index is numerical index from 0 to 100. (\>25 = pain)

    Time frame: Day: 0

  3. Anxiety felt during balloon placement

    Anxiety felt during balloon placement measured by a numerical scale from 0 to 10 : 0 = no anxiety - 10 = maximum anxiety.

    Time frame: Day: 0

  4. difficulty of balloon placement by the midwife during induction of labor

    Difficulty of balloon placement by the midwife is measured by questionary classified as very easy / easy / ni easy ni difficult / difficult / very difficult

    Time frame: Day: 0

  5. patient's satisfaction with the use of the virtual reality headset.

    patient's satisfaction is evaluated by Likert scale: Completely satisfied/ Satisfied/ Neutral/ Not satisfied/ Not at all satisfied

    Time frame: Day: 0

  6. midwife's satisfaction with the use of the virtual reality headset.

    midwife's satisfaction is evaluated by Likert scale: Completely satisfied/ Satisfied/ Neutral/ Not satisfied/ Not at all satisfied

    Time frame: Day: 0

  7. tolerance of the virtual reality helmet by the patient.

    Tolerance is a composite outcome : nausea (YES/NO), dizziness (YES/NO), premature stopping (YES/NO)

    Time frame: Day: 0

07

Study locations

1 site
  • CHU de Saint-Etienne
    Saint-Etienne, 42055, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2022 to primary completion in Feb 2023, 12 months.

Of 18 interventional studies with no phase under Dystocia, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 40. This study's 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 1, 2021
First posted
Dec 14, 2021
StartActual
Feb 1, 2022
Primary completionActual
Feb 28, 2023
CompletionActual
Feb 28, 2023
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05155826
Responsible party
Sponsor
First posted
Dec 14, 2021
Start date
Feb 1, 2022
Primary completion
Feb 28, 2023
Completion
Feb 28, 2023
Last update
Jun 30, 2026

Study contacts

Tiphaine RAIA BARJAT, MD
principal investigator · Centre Hospitalier Universitaire de Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion